-+ 0.00%
-+ 0.00%
-+ 0.00%

LEADS BIOLABS' PD-L1/4-1BB BISPECIFIC ANTIBODY IND APPLICATION FOR COMBINATION THERAPY IN METASTATIC COLORECTAL CANCER APPROVED, FURTHER STRENGTHENING GASTROINTESTINAL ONCOLOGY FRANCHISE

路透·08/03/2026 03:43:25

登錄查看新聞詳情